secwatch.observer — SEC 8-K summary
======================================

Issuer:     Inogen Inc (INGN)
CIK:        0001294133
Form:       8-K
Filed at:   2023-09-18T23:59:59+00:00
Accession:  0000950170-23-048471
Event type: m_and_a
Sentiment:  positive
Materiality: 0.65
Item codes: 2.01, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Inogen completes acquisition of Physio-Assist for ~$32M cash plus up to $13M earnout
--------------------------------------------------------------------------------

- Paid ~$32M cash at closing, subject to net debt adjustment; potential earnout up to $13M if FDA clearance within 4 years.
- Physio-Assist's Simeox airway clearance device targets bronchiectasis; 400k-490k US patient population.
- Simeox CE-marked, sold in Europe/Asia/Middle East; Inogen to pursue FDA submission.
- Expected immaterial to 2023 revenue, immediately accretive to gross margin, accretive to adjusted earnings by 2027.
- Recurring revenue from disposables in addition to capital sales per device.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1294133/000095017023048471/0000950170-23-048471-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1294133/000095017023048471/ingn-20230914.htm
  HTML page:      https://secwatch.observer/filing/0000950170-23-048471

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer